Publications

KeywordTopicPublication Type
  • in Grantee Publication by Schiavoni, K.H., Lehmann, L.S., Guan, W., Rosenthal, M., Sequist, T.D., and Chien, A.T.

    Little is known about how primary care physicians (PCPs) in routine outpatient practice use paid price information (i.e., the amount that insurers finally pay providers) in daily clinical practice. In this HCFO-funded study, the researchers used semi-structured interviews and qualitative analysis to describe the experiences of PCPs who have had paid price information on tests and procedures for at least one year.

  • in Policy Brief by Gabel, J. et al.

    This brief summarizes findings from a study’s evaluation of a large Midwestern health information technology firm that offered their employees a price transparency tool.

  • in Grantee Publication by Robinson, J.C., Whaley, C., and Brown, T.T.

    Prices for laboratory and other clinical services vary widely. Employers and insurers increasingly are adopting “reference pricing” policies to create incentives for patients to select lower-priced facilities. In this HCFO-funded study, the researchers measured the association between implementation of reference pricing and patient choice of laboratory, test prices, patient out-of-pocket spending, and insurer spending.

  • in Grantee Publication by Sinaiko, A.D.

    Tiered physician networks are a managed care network design used by payers to contain health care costs and improve value in the health care system. Prior studies found that tiered provider networks channel patients to preferred providers in certain contexts. This paper evalautes whether the effects of tiered physician networks vary for different types of patients.

  • in Study Snapshot by Bernstein, J.

    This executive summary provides an overview of the discussion from a May 2016 meeting where RWJF grantees presented some of the key findings from their research on the use and impact of price data in health care to a panel of experts actively engaged in developing and using health care price information.

  • in Policy Brief by Bernstein, J.

    This issue brief summarizes the discussion from a May 2016 meeting where RWJF grantees presented some of the key findings from their research on the use and impact of price data in health care to a panel of experts actively engaged in developing and using health care price information.

  • in Study Snapshot by HCFO

    Accountable Care Organizations (ACO) emerged as a novel payment model to create a coordinated health system whereby providers contract together to take collective responsibility for managing the cost and quality of care for a population of patients. Preventive care is critical to ACO success. Evaluating ACOs’ strategic choices in terms of their organizational structure and early performance provides an avenue to a better understanding of the factors behind preventive care quality. In a HCFO-funded study, Valerie Lewis, Ph.D., of Dartmouth College and colleagues conducted a cross-sectional study examining Medicare Shared Savings Program and Pioneer ACO Program participants and the association between preventive care quality performance and ACO characteristics to inform strategies for preventive care quality management.

  • in Findings Brief by HCFO

    During the past decade, preventive care in medicine has become a national priority. Accountable Care Organizations (ACO) emerged as a novel payment model to create a coordinated health system whereby providers contract together to take collective responsibility for managing the cost and quality of care for a population of patients. Preventive care is critical to ACOs’ success. In a HCFO-funded study, Valerie Lewis, Ph.D., of Dartmouth College and colleagues conducted a cross-sectional study examining Medicare Shared Savings Program (MSSP) and Pioneer ACO Program participants and the association between preventive care quality performance and ACO characteristics. Their goal was to inform strategies for preventive care quality management.

  • in Grantee Publication by Mehrotra, A. and Ashwood, J.S.

    This letter is a response to a critique of the researchers' publication, "Retail Clinic Visits For Low-Acuity Conditions Increase Utilization And Spending", published in the March 2016 Health Affairs.

  • in Grantee Publication by Maciejewski, M.L., Hammill, B.G., Qualls, L.G., Hastings, S.N., Wang, V., and Curtis, L.H.

    Laboratory testing to identify contraindications and adverse drug reactions is important for safety of patients initiating angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs). Rates and predictors of appropriate testing among Medicare fee-for-service beneficiaries are unknown. In this HCFO-funded study, the researchers examined baseline laboratory testing rates to identify predictors of suboptimal testing and to assess the prevalence of abnormal creatinine and potassium among beneficiaries initiating ACE inhibitors or ARBs.